Cornerstone Therapeutics appoints new CFO
This article was originally published in Scrip
Executive Summary
Cornerstone Therapeutics, a speciality pharmaceutical company focused on the acquisition, development and commercialisation of proprietary products for the respiratory and related markets, has appointed Vincent Morgus executive vice-president, finance, and chief financial officer. Mr Morgus joins from Quintiles, where he has been senior vice-president of corporate development since 2003.